Patent ID: 8828952

Claim:
A compound of the general formula: [X] n —Y—ZR 1 R 2 I wherein: X and Y are each a monosaccharide unit wherein each hydroxyl group not involved in a glycosidic linkage is substituted independently by a group SO 3 M or H, where M is any pharmaceutically acceptable cation; X and Y are any D - or L -hexose or pentose; Y is in a cyclic or ring opened form; Z is O, N, S or C or their higher oxidation states, or a bond, and is linked to the anomeric carbon when Y is a reducing monosaccharide; R 1 is a linker selected from the group consisting of: alkyl, alkenyl, alkynyl, aryl, heteroalkyl, heteroaryl, acyl, aroyl, alkylamido, alkylthioamido, triazolyl, substituted triazolyl, and oxymethyl[1,2,3]-triazole-1-yl linker, or is a bond, wherein if R 1 is substituted triazolyl, the triazolyl is substituted by one or more of: halo, hydroxy, C1-6alkyl, C1-6alkoxy, nitro, amino, C1-6alkylamino, C1-6dialkylamino, halomethyl, halomethoxy or acetyl; R 2 is a lipophilic moiety selected from the group consisting of: cholestanyl, and propylstearamide, wherein n is an integer from 0-6; and the level of sulfation of each compound is between 70 and 100% of the total hydroxyl groups.